Your browser doesn't support javascript.
loading
History of cholelithiasis and cancer risk in a network of case-control studies.
Tavani, A; Rosato, V; Di Palma, F; Bosetti, C; Talamini, R; Dal Maso, L; Zucchetto, A; Levi, F; Montella, M; Negri, E; Franceschi, S; La Vecchia, C.
Afiliação
  • Tavani A; Department of Epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan. Electronic address: alessandra.tavani@marionegri.it.
  • Rosato V; Department of Epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan.
  • Di Palma F; Department of Epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan.
  • Bosetti C; Department of Epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan.
  • Talamini R; Unit of Epidemiology and Biostatistics, Centro di Riferimento Oncologico, Aviano.
  • Dal Maso L; Unit of Epidemiology and Biostatistics, Centro di Riferimento Oncologico, Aviano; Department of Occupational Health, University of Milan, Milan, Italy.
  • Zucchetto A; Unit of Epidemiology and Biostatistics, Centro di Riferimento Oncologico, Aviano.
  • Levi F; Cancer Epidemiology Unit and Registre Vaudois des Tumeurs, Institut universitaire de médecine sociale et préventive, Lausanne, Switzerland.
  • Montella M; Unit of Epidemiology, Istituto Tumori "Fondazione Pascale", Naples, Italy.
  • Negri E; Department of Epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan.
  • Franceschi S; International Agency for Research on Cancer, Lyon.
  • La Vecchia C; Department of Epidemiology, Istituto di Ricerche Farmacologiche "Mario Negri", Milan; Department of Occupational Health, University of Milan, Milan, Italy; International Prevention Research Institute, Lyon, France.
Ann Oncol ; 23(8): 2173-2178, 2012 Aug.
Article em En | MEDLINE | ID: mdl-22231026
ABSTRACT

BACKGROUND:

We analyzed the relationship between cholelithiasis and cancer risk in a network of case-control studies conducted in Italy and Switzerland in 1982-2009.

METHODS:

The analyses included 1997 oropharyngeal, 917 esophageal, 999 gastric, 23 small intestinal, 3726 colorectal, 684 liver, 688 pancreatic, 1240 laryngeal, 6447 breast, 1458 endometrial, 2002 ovarian, 1582 prostate, 1125 renal cell, 741 bladder cancers, and 21 284 controls. The odds ratios (ORs) were estimated by multiple logistic regression models.

RESULTS:

The ORs for subjects with history of cholelithiasis compared with those without were significantly elevated for small intestinal (OR=3.96), prostate (OR=1.36), and kidney cancers (OR=1.57). These positive associations were observed ≥10 years after diagnosis of cholelithiasis and were consistent across strata of age, sex, and body mass index. No relation was found with the other selected cancers. A meta-analysis including this and three other studies on the relation of cholelithiasis with small intestinal cancer gave a pooled relative risk of 2.35 [95% confidence interval (CI) 1.82-3.03].

CONCLUSION:

In subjects with cholelithiasis, we showed an appreciably increased risk of small intestinal cancer and suggested a moderate increased risk of prostate and kidney cancers. We found no material association with the other cancers considered.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colelitíase / Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2012 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Colelitíase / Neoplasias Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2012 Tipo de documento: Article